Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 2 min ago

Provista Diagnostics Secures $6MM Series B Financing

Wed, 04/16/2014 - 13:05
Scottsdale, Arizona, April 16, 2014 -- (Healthcare Sales & Marketing Network) -- Provista Diagnostics, Inc., a privately held molecular diagnostics company developing and commercializing diagnostic, prognostic and predictive tests for cancers affecting wom...
Diagnostics, Oncology, Venture Capital
Provista Diagnostics, dtectDx-Breast

OxThera AB Receives SEK 70 Million Financing to Continue its Key Clinical Programs

Wed, 04/16/2014 - 12:59
STOCKHOLM, April 16, 2014 -- (Healthcare Sales & Marketing Network) -- OxThera AB, a privately-held Stockholm-based biopharmaceutical company, today announced that a syndicate of new investors, led by Kurma Partners, including IdInvest Partners and Mayo C...
Biopharmaceuticals, Venture Capital
OxThera AB, Oxabact, Primary Hyperoxaluria

Wilson Therapeutics Secures $40 Million Private Financing To Advance Late Stage Development Program For Wilson's Disease

Wed, 04/16/2014 - 12:53
STOCKHOLM, April 16, 2014 -- (Healthcare Sales & Marketing Network) -- Wilson Therapeutics, a biopharmaceutical company, today announced that it has closed a $40 million Series B financing co-led by new investors, Abingworth LLP and MVM Life Science Partn...
Biopharmaceuticals, Venture Capital
Wilson Therapeutics, WTX101, Wilson's disease

Abiomed Acquires Exclusive License for Opsens' Optical Sensor Technology

Tue, 04/15/2014 - 15:18
Miniature Optical Pressure Sensors to be Integrated Into Impella Heart Pump Catheters DANVERS, Mass., April 15, 2014 -- (Healthcare Sales & Marketing Network) -- Abiomed, Inc. (ABMD), a leading provider of break-through heart support technologies, today...
Devices, Cardiology, Licensing
Abiomed, Opsens , fiber optic sensor, pressure sensor, Impella

Eventus Diagnostics Completes $2.72 Million Financing To Support Commercialization Of Its Octava(TM) Blood Tests For Breast Cancer Detection

Tue, 04/15/2014 - 15:13
Octava™ Breast Cancer Tests Are Designed for Adjunctive Use with Screening Mammography to Help Identify False Positive and False Negative Results Octava Tests are CE Marked and in Pilot Distribution in Europe Octava™ Pink Recently Approved by Israel ...
Diagnostics, Oncology, Venture Capital
Eventus Diagnostics, Octava test, breast cancer test

Interim Results of AirXpanders' Multi-Centered Randomized Controlled Trial Demonstrate Faster, Needle-Free Alternative to Saline Tissue Expanders

Tue, 04/15/2014 - 13:56
Highly statistically significant improvement in expansion and total implant times compared to saline Interim results of the XPAND trial published in the April 2014 issue of Plastic and Reconstructive Surgery PALO ALTO, Calif., April 15, 2014 -- (Heal...
AirXpanders, XPAND trial, AeroForm, tissue expansion

Reverse Medical(R) Corporation Announces FDA IDE Approval for the BARREL(R) Vascular Reconstruction Device for the Treatment of Intracranial Bifurcation Aneurysms

Tue, 04/15/2014 - 13:34
IRVINE, Calif.--(Healthcare Sales & Marketing Network)--Reverse Medical® Corporation today announced FDA IDE approval for clinical investigation of their BARREL® Vascular Reconstruction Device (VRD). The BARREL® Vascular Reconstruction Device i...
Devices, Interventional, Neurosurgery, FDA
Reverse Medical, BARREL VRD, intracranial bifurcation, aneurysm

AAVLife Raises $12 Million in Series A Financing to Advance Gene Therapy for Friedreich’s Ataxia

Tue, 04/15/2014 - 13:18
Report in Nature Medicine Shows Promise Of Treatment for Life-Threatening Cardiac Symptoms PARIS--(Healthcare Sales & Marketing Network)--AAVLife, a gene-therapy company focusing on rare diseases, today announced that it has raised $12 million in Serie...
Biopharmaceuticals, Neurology, Venture Capital
AAVLife, Friedreich’s ataxia, gene therapy

Mevion Medical Systems Announces An Exclusive Partnership with Chiyoda Technol Corporation for Distribution of the MEVION S250 Proton Therapy System in Japan

Mon, 04/14/2014 - 21:43
LITTLETON, Mass.--(Healthcare Sales & Marketing Network)--Mevion Medical Systems is pleased to announce an agreement with Chiyoda Technol Corporation for the exclusive distribution of the MEVION S250 Proton Therapy System in the Japanese market. Chiyoda Te...
Devices, Oncology, Distribution
Mevion Medical Systems, Proton Therapy, proton beam, radiotherapy

Syneron Receives US FDA Clearance to Market the UltraShape System for Fat Cell Destruction

Mon, 04/14/2014 - 21:37
Positions Syneron with Disruptive Product Offering in Fast Growing Body Contouring and Fat Treatment Market IRVINE, California, April 14, 2014 -- (Healthcare Sales & Marketing Network) -- Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in t...
Devices, Dermatology, FDA
Syneron Medical, UltraShape System, fat cell destruction, body shaping

Abbott Announces FDA Clearance for a New Test to Help Physicians Quickly and Accurately Diagnose Diabetes

Mon, 04/14/2014 - 21:32
New Abbott test could help physicians diagnose people in the U.S. who are unaware that they have diabetes, empowering them to control their disease ABBOTT PARK, Ill., April 14, 2014 -- (Healthcare Sales & Marketing Network) -- Abbott (ABT) announced to...
Diagnostics, Endocrinology, FDA
Abbott, ARCHITECT HbA1c, diabetes

ZELTIQ Announces FDA Clearance to Treat Thighs

Mon, 04/14/2014 - 21:25
Newest Indication Adds Thighs to List of Problem Areas Successfully Treated by CoolSculpting(R) Procedure PLEASANTON, CA--(Healthcare Sales & Marketing Network) - ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing...
Devices, Dermatology, FDA
ZELTIQ Aesthetics, CoolSculpting, CoolSmooth, CoolFit applicator

Medicrea Announces European Launch of UNiD, the World’s First Patient-Specific Spinal Rod

Mon, 04/14/2014 - 21:14
LYON, France--(Healthcare Sales & Marketing Network)--The MEDICREA group (ALMED.PA) (Alternext Paris: FR0004178572-ALMED), a company that specializes in the development of innovative surgical technologies for the treatment of spinal pathologies, today anno...
Devices, Orthopaedic, Neurosurgery, Product Launch
MEDICREA, spinal osteosynthesis, UNiD rod, spine surgery

Kite Pharma Expands Leadership Team and Announces Senior Management Promotions

Mon, 04/14/2014 - 12:59
SANTA MONICA, Calif., April 14, 2014 -- (Healthcare Sales & Marketing Network) -- Kite Pharma, Inc. (Kite), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT™) products for the treatment of cancer,...
Biopharmaceuticals, Personnel
Kite Pharma, eACT

Covidien Announces U.S. Food and Drug Administration 510(k) Clearance for the Kangaroo(TM) Feeding Tube with IRIS Technology

Mon, 04/14/2014 - 12:53
New feeding tube with integrated camera designed to deliver enhanced patient safety DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien plc (COV) today announced U.S. Food and Drug Administration 510(k) Clearance for the Kangaroo™ feeding ...
Devices, FDA
Covidien, Kangaroo feeding tube, IRIS Technology, feeding tube

Synthetic Biologics Appoints Mark Pimentel, M.D., Chairman of New Irritable Bowel Syndrome Clinical Advisory Board

Mon, 04/14/2014 - 12:33
ROCKVILLE, Md., April 14, 2014 -(Healthcare Sales & Marketing Network)- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and other disease...
Biopharmaceuticals, Personnel
Synthetic Biologics

Alimera Sciences Announces New PDUFA Date For ILUVIEN(R)

Mon, 04/14/2014 - 12:26
PDUFA goal date set for September 26, 2014 ATLANTA, April 14, 2014 -- (Healthcare Sales & Marketing Network) -- Alimera Sciences, Inc. (ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of ...
Biopharmaceuticals, Ophthalmology
Alimera Sciences, ILUVIEN, intravitreal implant, diabetic macular edema

Auxilium and Sobi Announce Encore Presentation of XIAFLEX/Xiapex Data at European Association of Urology Congress

Mon, 04/14/2014 - 12:19
Encore Data Highlighted from Trials Evaluating XIAFLEX, the First and Only FDA Approved Treatment for Peyronie's Disease CHESTERBROOK, Pa. and STOCKHOLM, April 14, 2014 -- (Healthcare Sales & Marketing Network) -- Auxilium Pharmaceuticals, Inc. (AUXL) ...
Biopharmaceuticals, Urology
Auxilium Pharmaceuticals, Swedish Orphan Biovitrum, XIAFLEX, Xiapex, Peyronie's

Toshiba Is First CT Manufacturer to Meet Security Guidelines of the U.S. Department of Defense for Connection to Air Force Network

Mon, 04/14/2014 - 12:11
TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--Toshiba America Medical Systems, Inc. received approval to operate (ATO) with the U.S. Air Force, making Toshiba the only current manufacturer to have a fully certified CT system for use on the Air Fo...
Devices, Radiology
Toshiba America Medical Systems, ATO status

Covidien Implements Voluntary Recall of its Pipeline(TM) Embolization Device and Alligator(TM) Retrieval Device

Fri, 04/11/2014 - 15:04
DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien plc today announced that it has notified customers of a voluntary recall to address an issue with certain lots of its Pipeline™ Embolization Device and Alligator™ Retrieval Device where the ...
Devices, Product Recall
Covidien, Pipeline Embolization Device, Alligator Retrieval Device

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong